Insulin glargine and lixisenatide Subcutaneous and Vimpat (Lacosamide Tablets)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Vimpat (Lacosamide Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: lacosamide
Brand name: Vimpat
Synonyms: Vimpat
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Vimpat Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Vimpat Oral Solution
- Insulin glargine and lixisenatide Subcutaneous-Vinacal
- Insulin glargine and lixisenatide Subcutaneous-Vinate
- Insulin glargine and lixisenatide Subcutaneous-Vinate AZ
- Insulin glargine and lixisenatide Subcutaneous-Vinate Care (Prenatal Vitamin Chewable Tablet Without Vitamin A)
- Vimpat (Lacosamide Tablets)-Insulin glargine, recombinant Subcutaneous
- Vimpat (Lacosamide Tablets)-Insulin glulisine
- Vimpat (Lacosamide Tablets)-Insulin Glulisine (Cartridges and Pens)
- Vimpat (Lacosamide Tablets)-Insulin Glulisine (Vials)
- Vimpat (Lacosamide Tablets)-Insulin glulisine Subcutaneous
- Vimpat (Lacosamide Tablets)-Insulin human inhaled Inhalation